Literature DB >> 19669364

Induction of tropomyosin during hepatic stellate cell activation and the progression of liver fibrosis.

Kohji Otogawa1, Tomohiro Ogawa, Ryoko Shiga, Kazuo Ikeda, Norifumi Kawada.   

Abstract

The activation of hepatic stellate cells (HSCs) is a cue to initiate liver fibrosis. Activated stellate cells acquire contractile activity similar to pericytes and myofibroblasts in other organs by inducing the contractile machinery of cytoskeletons such as smooth muscle alpha-actin (alpha-SMA), a well-known marker of activated stellate cells, and actin-binding proteins. We further show herein the expression of tropomyosin in rat HSCs in the course of their activation during primary culture and liver tissue damaged by thioacetamide intoxication. In immunoblot analysis, tropomyosin became detectable in an early stage of the primary culture of rat stellate cells in a manner similar to the expression of alpha-SMA and platelet-derived growth factor receptor-beta. Tropomyosin was found to be colocalized with alpha-SMA on fluorescent immunocytochemistry. At the liver tissue level, an increased expression of tropomyosin was observed by immunoblot analysis and immunohistochemistry along the septum of fibrosis, where alpha-SMA was enriched. These results strongly suggest that tropomyosin is a new marker of activated stellate cells and may serve as a useful diagnostic marker of liver fibrosis.

Entities:  

Year:  2008        PMID: 19669364      PMCID: PMC2716761          DOI: 10.1007/s12072-008-9113-y

Source DB:  PubMed          Journal:  Hepatol Int        ISSN: 1936-0533            Impact factor:   6.047


  28 in total

Review 1.  The hepatic stellate cell in the post-genomic era.

Authors:  H Okuyama; Y Shimahara; N Kawada
Journal:  Histol Histopathol       Date:  2002-04       Impact factor: 2.303

Review 2.  Liver fibrogenesis: a new role for the renin-angiotensin system.

Authors:  Ramón Bataller; Pau Sancho-Bru; Pere Ginès; David A Brenner
Journal:  Antioxid Redox Signal       Date:  2005 Sep-Oct       Impact factor: 8.401

3.  The troponin binding region of tropomyosin. Evidence for a site near residues 197 to 127.

Authors:  A D McLachlan; M Stewart
Journal:  J Mol Biol       Date:  1976-10-05       Impact factor: 5.469

4.  Tropomyosin has discrete actin-binding sites with sevenfold and fourteenfold periodicities.

Authors:  S E Hitchcock-DeGregori; T A Varnell
Journal:  J Mol Biol       Date:  1990-08-20       Impact factor: 5.469

Review 5.  The hepatic perisinusoidal stellate cell.

Authors:  N Kawada
Journal:  Histol Histopathol       Date:  1997-10       Impact factor: 2.303

6.  Induction of the lipocyte phenotype in murine hepatic stellate cells: reorganisation of the actin cytoskeleton.

Authors:  C S Mermelstein; F C Guma; T G Mello; V A Fortuna; R M Guaragna; M L Costa; R Borojevic
Journal:  Cell Tissue Res       Date:  2001-10       Impact factor: 5.249

Review 7.  Perisinusoidal stellate cells of the liver: important roles in retinol metabolism and fibrosis.

Authors:  R Blomhoff; K Wake
Journal:  FASEB J       Date:  1991-03-01       Impact factor: 5.191

8.  Endothelin antagonism in experimental hepatic fibrosis. Implications for endothelin in the pathogenesis of wound healing.

Authors:  D C Rockey; J J Chung
Journal:  J Clin Invest       Date:  1996-09-15       Impact factor: 14.808

9.  Tropomyosin interacts with phosphorylated HSP27 in agonist-induced contraction of smooth muscle.

Authors:  Sita Somara; Khalil N Bitar
Journal:  Am J Physiol Cell Physiol       Date:  2004-01-28       Impact factor: 4.249

10.  Role of mesenchymal cell populations in porcine serum-induced rat liver fibrosis.

Authors:  E Bhunchet; K Wake
Journal:  Hepatology       Date:  1992-12       Impact factor: 17.425

View more
  6 in total

1.  Interleukin-9 blockage reduces early hepatic granuloma formation and fibrosis during Schistosoma japonicum infection in mice.

Authors:  Tingzheng Zhan; Huihui Ma; Suqin Jiang; Zirong Zhong; Xiaoli Wang; Chunxiang Li; Dan Yu; Lei Liu; Jing Xu; Chaoming Xia
Journal:  Immunology       Date:  2019-09-17       Impact factor: 7.397

2.  Differential patterns of liver proteins in experimental murine hepatosplenic schistosomiasis.

Authors:  B Manivannan; P Rawson; T W Jordan; W E Secor; A C La Flamme
Journal:  Infect Immun       Date:  2009-11-23       Impact factor: 3.441

3.  miR-29c is downregulated in renal interstitial fibrosis in humans and rats and restored by HIF-α activation.

Authors:  Yi Fang; Xiaofang Yu; Yong Liu; Alison J Kriegel; Yanyan Heng; Xialian Xu; Mingyu Liang; Xiaoqiang Ding
Journal:  Am J Physiol Renal Physiol       Date:  2013-03-06

4.  Transcriptomic Profiling of the Liver Sinusoidal Endothelium during Cirrhosis Reveals Stage-Specific Secretory Signature.

Authors:  Nicolò Manicardi; Anabel Fernández-Iglesias; Laia Abad-Jordà; Felix Royo; Mikel Azkargorta; Martí Ortega-Ribera; David Sanfeliu-Redondo; Ana Martínez-Alcocer; Felix Elortza; Amelia J Hessheimer; Constantino Fondevila; Juan José Lozano; Juan Carlos García-Pagán; Jaime Bosch; Francisco Javier Cubero; Agustín Albillos; Javier Vaquero; Juan M Falcón-Pérez; Jordi Gracia-Sancho
Journal:  Cancers (Basel)       Date:  2021-05-29       Impact factor: 6.639

5.  Genome-wide CRISPR Screening to Identify Drivers of TGF-β-Induced Liver Fibrosis in Human Hepatic Stellate Cells.

Authors:  Shan Yu; Matthew Ericson; Andrea Fanjul; Derek M Erion; Maria Paraskevopoulou; Erin N Smith; Banumathi Cole; Ryan Feaver; Corine Holub; Narender Gavva; Shane R Horman; Jie Huang
Journal:  ACS Chem Biol       Date:  2022-03-11       Impact factor: 4.634

6.  Arecoline suppresses epithelial cell viability by upregulating tropomyosin-1 through the transforming growth factor-β/Smad pathway.

Authors:  Long Li; Liqun Gu; Zhigang Yao; Yuehong Wang; Zhangui Tang; Xiaoying Wu
Journal:  Pharm Biol       Date:  2020-11-18       Impact factor: 3.889

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.